Freezing out kidney cancer: new device tested on 120 patients
NCT ID NCT02399124
First seen Jan 11, 2026 · Last updated May 02, 2026 · Updated 17 times
Summary
This study tests a freezing treatment called cryotherapy for kidney cancer (renal cell carcinoma). It involves 120 adults with tumors up to 5 cm. The goal is to see if the ProSense™ system can safely freeze the entire tumor plus a small margin, and track if the cancer comes back over 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bnei Zion Medical Center
Haifa, Israel
-
Shamir Medical Center
Ẕerifin, 70300, Israel
Conditions
Explore the condition pages connected to this study.